As M&A investments could hit $400 billion this year, watch for buys in health technology and data, biotech, pharma and medical devices.
Aflac is a dividend aristocrat that offers a safe yield and strong total returns.
CVS has strong fundamentals, a good price, and plenty of room to catch up.
Well-regarded supplemental health care insurance firm Aflac sports an 'A' for financial strength -- here's how to play it at this great valuation.
The Travelers Companies should provide an umbrella during a recession and has a strong dividend track record.
Ebix Inc. provides enterprise cloud e-commerce products for the insurance, finance and health care industries, and it's a great way to play the software-as-a-service theme for a low price.
Studies appear to back up some cannabis products' use in helping users catch needed z's.
The market was looking for an excuse to sell off and come back to more normal levels, and now we have the pandemic that is the coronavirus.
The NYSE used to be the center of capitalism, but now it's where actual engineering, not financial engineering, is taking place.
Here's how two big events early this week make me view this name that's one of my favorite undervalued, dividend-paying companies.